A compound according to formula (I) wherein X is phenyl; R 1 and R 2 are independently selected from the group consisting of H, OH, -(C 1 -C 6 )alkyl-OH, halo, NH 2 , NOH, NHOH, and CN; or R 1 and R 2 , if bound to adjacent carbon atoms, in combination with the existing carbon-carbon bond represent a double bond between the adjacent carbon atoms; R 3 and R 4 are independently selected from the group consisting of H, (C 1- C 6 )alkyl, (C 3- C 8 )cycloalkyl, (C 1- C 6 )haloalkyl, CN, and halo; wherein one of R 3 and R 4 is -CF 3 ; m is 1; W is CH 2 , O or, NH; V is selected from the group consisting of H, (C 1 -C 10 )alkyl, (C 2 -C 12 )alkenyl, -(C 1 -C 10 )alkyl-(C 6 -C 10 )aryl, -(C 2 -C 12 )alkenyl-(C 6 -C 10 )aryl, -(C 1 -C 10 )alkyl-(C 6 -C 10 )aryl-(C 1 -C 10 )alkyl,-(C 1 -C 10 )alkyl-(C 3 -C 8 )cycloalkyl, -(C 1 -C 10 )alkyl-heterocyclyl containing from 1 to 3 ring heteroatoms selected from N, O, and S; wherein any aryl is optionally fused to (C 6 -C 10 )aryl, (C 3 -C 8 )cycloalkyl, or heterocyclyl containing from 1 to 3 ring heteroatoms selected from N, O, and S wherein any alkyl, alkenyl, cycloalkyl, heterocyclyl, or aryl is optionally substituted by 1 - 4 substituents independently selected from the group consisting of F, Cl, Br, (C 1 -C 6 )alkyl, -O-(C 1 -C 6 )alkyl, (C 2 -C 6 )alkenyl, (C 1 -C 6 )haloalkyl, (C 6 -C 10 )aryl, and CN; Y 1 is N; Y 2 is N and Y 3 is O, or Y 2 is O and Y 3 is N; or a pharmaceutically acceptable salt thereof. X is phenyl; R 1 and R 2 are independently selected from the group consisting of H, OH, -(C 1 -C 6 )alkyl-OH, halo, NH 2 , NOH, NHOH, and CN; or R 1 and R 2 , if bound to adjacent carbon atoms, in combination with the existing carbon-carbon bond represent a double bond between the adjacent carbon atoms; R 3 and R 4 are independently selected from the group consisting of H, (C 1- C 6 )alkyl, (C 3- C 8 )cycloalkyl, (C 1- C 6 )haloalkyl, CN, and halo; wherein one of R 3 and R 4 is -CF 3 ; m is 1; W is CH 2 , O or, NH; V is selected from the group consisting of H, (C 1 -C 10 )alkyl, (C 2 -C 12 )alkenyl, -(C 1 -C 10 )alkyl-(C 6 -C 10 )aryl, -(C 2 -C 12 )alkenyl-(C 6 -C 10 )aryl, -(C 1 -C 10 )alkyl-(C 6 -C 10 )aryl-(C 1 -C 10 )alkyl,-(C 1 -C 10 )alkyl-(C 3 -C 8 )cycloalkyl, -(C 1 -C 10 )alkyl-heterocyclyl containing from 1 to 3 ring heteroatoms selected from N, O, and S; wherein any aryl is optionally fused to (C 6 -C 10 )aryl, (C 3 -C 8 )cycloalkyl, or heterocyclyl containing from 1 to 3 ring heteroatoms selected from N, O, and S wherein any alkyl, alkenyl, cycloalkyl, heterocyclyl, or aryl is optionally substituted by 1 - 4 substituents independently selected from the group consisting of F, Cl, Br, (C 1 -C 6 )alkyl, -O-(C 1 -C 6 )alkyl, (C 2 -C 6 )alkenyl, (C 1 -C 6 )haloalkyl, (C 6 -C 10 )aryl, and CN; wherein any aryl is optionally fused to (C 6 -C 10 )aryl, (C 3 -C 8 )cycloalkyl, or heterocyclyl containing from 1 to 3 ring heteroatoms selected from N, O, and S wherein any alkyl, alkenyl, cycloalkyl, heterocyclyl, or aryl is optionally substituted by 1 - 4 substituents independently selected from the group consisting of F, Cl, Br, (C 1 -C 6 )alkyl, -O-(C 1 -C 6 )alkyl, (C 2 -C 6 )alkenyl, (C 1 -C 6 )haloalkyl, (C 6 -C 10 )aryl, and CN; Y 1 is N; Y 2 is N and Y 3 is O, or Y 2 is O and Y 3 is N; <EOS>